| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $217.5M | +3.8% | +3.1% |
| Cost of Revenue | $160.0M | +5.2% | +6.9% |
| Gross Profit | $57.5M | +0.0% | -6.1% |
| R&D Expense | $78K | +90.2% | +30.0% |
| SG&A Expense | $51.2M | +24.7% | +11.3% |
| Operating Income | -$22.3M | -1165.0% | +47.2% |
| Pre-tax Income | -$40.0M | -5076.6% | +52.0% |
| Income Tax | $3.5M | +255.2% | +74.2% |
| Net Income | -$44.9M | — | +47.4% |
| EPS (Basic) | -$0.41 | — | -310.0% |
| EPS (Diluted) | -$0.41 | — | -310.0% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $246.7M | -6.8% | +30.1% |
| Short-term Investments | $44.8M | — | -28.3% |
| Accounts Receivable | $109.1M | +1.9% | -3.3% |
| Inventory | $283.2M | +0.1% | +6.5% |
| Current Assets | $729.3M | +4.0% | +3.1% |
| Total Assets | $2.10B | +0.8% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$9.9M | -636.6% | — |
| Investing Cash Flow | -$33.5M | -237.1% | — |
| Financing Cash Flow | $67.9M | +242.3% | — |
| -49.9% |
| Current Liabilities | $259.3M | -3.1% | -6.9% |
| Total Liabilities | $552.1M | -1.8% | -25.2% |
| Stockholders' Equity | $1.58B | +2.5% | -54.5% |